Lv1
30 积分 2026-07-20 加入
Mechanisms of osteoclast activation in inflammatory bone loss in rheumatoid arthritis
1个月前
已完结
The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H+‐ATPase
1个月前
已完结
Cellular and molecular mechanisms of action of bisphosphonates
1个月前
已完结
Microfiber-Reinforced Composite Hydrogels Loaded with Rat Adipose-Derived Stem Cells and BMP-2 for the Treatment of Medication-Related Osteonecrosis of the Jaw in a Rat Model
1个月前
已完结
Biomaterial-Based Lymphangiogenesis-Enhanced Therapeutic Strategy for Robustly-Integrated Medication-Related Osteonecrosis of Jaw Prevention
1个月前
已完结
Macrophage Polarization during MRONJ Development in Mice
2个月前
已完结
Medication-related osteonecrosis of the jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies
2个月前
已完结
Sensory denervation increases potential of bisphosphonates to induce osteonecrosis via disproportionate expression of calcitonin gene–related peptide and substance P
2个月前
已完结
Alendronate sodium induces G1 phase arrest and apoptosis in human umbilical vein endothelial cells by inhibiting ROS-mediated ERK1/2 signaling
2个月前
已完结
Zoledronic Acid Regulates Osteoclasts via miR‐483‐5p in the BRONJ
2个月前
已完结
皖公网安备34019202002308
